Breaking News

Labcorp Launches Independent Clinical Development Business

Fortrea will provide Phase I through IV clinical trial management and commercialization services.

Labcorp, a global life sciences company, has formed Fortrea, a spin-off of its clinical development business. Upon completion of the spin-off from Labcorp, Fortrea will operate as an independent, publicly traded global Contract Research Organization (CRO), that offers comprehensive drug and medical device development services. Fortrea will employ more than 19,000 people, and provide Phase I through IV clinical trial management, and commercialization solutions to pharmaceutical and biotechn...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters